arrow
C

Carolina Martínez-Ciarpaglini

hospital clinico universitario de valencia
H指数:16
被引数:1,508

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Spatial Dynamics Links PD-L1 and Tumor-Associated Macrophage-Enriched Niches to Immune and Mesenchymal States in Microsatellite-Stable Colorectal Cancer

空间动力学将PD-L1与肿瘤相关巨噬细胞富集的微环境与免疫和间质状态联系起来,在微卫星稳定型结直肠癌中

Cancers
IF4.4
2026-04-180
OAAI
Prognostic impact of pathological complete response and response-adapted outcomes in patients with gastroesophageal adenocarcinoma treated with neoadjuvant or perioperative treatments: a multicentric cohort study

病理完全缓解和反应适应性结局对接受新辅助或围手术期治疗的患者中胃食管腺癌的预后影响:一项多中心队列研究

2026-03-030
OAAI
Interobserver variability of histopathological assessment in pT1 colorectal carcinoma

pT1 colorectal carcinoma的病理学评估结果在不同观察者之间的差异

2025-12-010
OAAI
CLDN18.2 expression in gastroesophageal adenocarcinoma: prevalence, heterogeneity, and prognostic implications in Spanish patients

胃食管腺癌中CLDN18.2的表达:在西班牙患者中的流行率、异质性和预后意义

2025-11-090
OAAI
Enhancing precision oncology: the role of molecular tumor boards in early identification and targeted treatment of ESCAT II-III alterations

增强精准肿瘤学:分子肿瘤委员会在早期识别和靶向治疗ESCAT II-III改变中的作用

2025-09-240
PREAI
A radiomics-based artificial intelligence model to assess the risk of relapse in localized colon cancer

一种基于放射组学的人工智能模型,用于评估局部结肠癌的复发风险

2025-07-160
OAAI
Extended tumor area-based stratification score combining tumor budding and stroma identifies a high-risk, immune-depleted group in localized microsatellite-stable colon cancer patients

基于扩展肿瘤区域并结合肿瘤出芽和间质的分层评分可识别局部微卫星稳定型结直肠癌患者中的高风险、免疫耗竭组

2025-05-010
PRE
Whole-exome tumor-agnostic ctDNA analysis enhances minimal residual disease detection and reveals relapse mechanisms in localized colon cancer

全外显子组肿瘤非特异性ctDNA分析增强了局部结直肠癌微小残留病灶的检测,并揭示了其复发机制

2025-04-290
OA
Immune profiling of gastric adenocarcinomas in EU and LATAM countries identifies global differences in immune subgroups and microbiome influence

欧盟和拉丁美洲国家胃腺癌的免疫分型研究,发现了免疫亚群和微生物组影响方面的全球性差异。

2025-03-200
OA
Biomarkers in gastroesophageal cancer 2025: an updated consensus statement by the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP)

胃肠癌生物标志物2025:西班牙医学肿瘤学会(SEOM)和西班牙病理学会(SEAP)联合发布的最新共识声明

2025-03-120
OA
Prognostic value of routine blood biomarkers in 3-year survival of resectable colorectal cancer patients: a prognostic nomogram for clinical practice

可切除结直肠癌患者3年生存率的常规血液生物标志物预测价值:临床实践中的预后列线图

2025-03-050
OA
Decoding chromosomal instability insights in CRC by integrating omics and patient-derived organoids

通过整合组学和患者源性类器官解码结直肠癌中的染色体不稳定性见解

2025-02-280
OA
Comprehensive histopathological analysis of gastric cancer in European and Latin America populations reveals differences in PDL1, HER2, p53 and MUC6 expression
2025-01-050
OAAI
COMPReS study: Multiomic profiling reveals organ-specific differences in metastases and identifies novel predictive biomarkers in relapsed localized colon cancer

COMPReS研究:多组学分析揭示了转移灶的器官特异性差异,并识别出局部复发结肠癌的新型预测性生物标志物

2024-09-011
PRE
EEG before chimeric antigen receptor T-cell therapy and early after onset of immune effector cell-associated neurotoxicity syndrome

嵌合抗原受体T细胞治疗前和免疫效应细胞相关神经毒性综合征发病后早期脑电图

2024-07-015
OAAI
Sequencing paired tumor DNA and white blood cells improves circulating tumor DNA tracking and detects pathogenic germline variants in localized colon cancer
2023-12-014
OAAI